ZeroStack Corp. (ZSTK)
4.86
+0.02
(+0.41%)
USD |
NASDAQ |
Oct 02, 16:00
4.85
-0.01
(-0.21%)
After-Hours: 20:00
ZeroStack Enterprise Value : 11.60M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 11.60M |
| October 01, 2026 | 11.55M |
| September 30, 2026 | 11.48M |
| September 29, 2026 | 11.55M |
| September 28, 2026 | 10.10M |
| September 25, 2026 | 9.682M |
| September 24, 2026 | 9.488M |
| September 23, 2026 | 9.318M |
| September 22, 2026 | 9.634M |
| September 21, 2026 | 10.29M |
| September 18, 2026 | 11.24M |
| September 17, 2026 | 10.73M |
| September 16, 2026 | 9.876M |
| September 15, 2026 | 11.26M |
| September 14, 2026 | 11.58M |
| September 11, 2026 | 11.55M |
| September 10, 2026 | 11.70M |
| September 09, 2026 | 10.08M |
| September 08, 2026 | 10.24M |
| September 04, 2026 | 10.24M |
| September 03, 2026 | 11.50M |
| September 02, 2026 | 12.14M |
| September 01, 2026 | 12.16M |
| August 31, 2026 | 12.62M |
| August 28, 2026 | 12.94M |
| Date | Value |
|---|---|
| August 27, 2026 | 14.08M |
| August 26, 2026 | 13.76M |
| August 25, 2026 | 15.51M |
| August 24, 2026 | 12.09M |
| August 21, 2026 | 11.24M |
| August 20, 2026 | 14.10M |
| August 19, 2026 | 11.84M |
| August 18, 2026 | 4.263M |
| August 17, 2026 | 4.530M |
| August 14, 2026 | 4.506M |
| August 13, 2026 | 3.845M |
| August 12, 2026 | 4.239M |
| August 11, 2026 | 3.888M |
| August 10, 2026 | 3.437M |
| August 07, 2026 | 3.802M |
| August 06, 2026 | 4.069M |
| August 05, 2026 | 4.312M |
| August 04, 2026 | 4.506M |
| August 03, 2026 | 3.996M |
| July 31, 2026 | 3.486M |
| July 30, 2026 | 3.534M |
| July 29, 2026 | 3.413M |
| July 28, 2026 | 3.072M |
| July 27, 2026 | 3.243M |
| July 24, 2026 | 3.316M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medical Marijuana, Inc. | 3.821M |
| Interpace Biosciences, Inc. | 31.67M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | 1.943M |
| Stella Diagnostics, Inc. | 21.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.62M |
| Revenue (Quarterly) | 13.66M |
| Total Expenses (Quarterly) | 38.27M |
| EPS Diluted (Quarterly) | -2.471 |
| Gross Profit Margin (Quarterly) | -7.63% |
| Profit Margin (Quarterly) | -180.2% |
| Earnings Yield | -2.47K% |
| Normalized Earnings Yield | -944.76 |